Avion Wealth’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Hold
92
﹤0.01% 1291
2025
Q4
$1K Hold
92
﹤0.01% 989
2025
Q3
$2K Hold
92
﹤0.01% 835
2025
Q2
$1K Hold
92
﹤0.01% 928
2025
Q1
$1K Hold
92
﹤0.01% 828
2024
Q4
$1K Hold
92
﹤0.01% 825
2024
Q3
$1K Hold
92
﹤0.01% 777
2024
Q2
$0 Hold
92
﹤0.01% 962
2024
Q1
$1K Hold
92
﹤0.01% 884
2023
Q4
$1K Buy
+92
New +$521 ﹤0.01% 725

Other funds holding CLPT

Avion Wealth's CLPT Position: Q1 2026 in Review

Avion Wealth held its ClearPoint Neuro (CLPT) position steady in Q1 2026 at 92 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Avion Wealth first reported a position in CLPT in Q4 2023 and has held it in 10 quarters since. The position peaked at $2K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Avion Wealth held 92 shares of ClearPoint Neuro worth $0 as of Q1 2026.
  • Avion Wealth left its ClearPoint Neuro share count unchanged in Q1 2026.
  • ClearPoint Neuro made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #1291 holding.
  • Avion Wealth first reported a position in ClearPoint Neuro in Q4 2023 and has held it in 10 quarters since.
  • Avion Wealth's ClearPoint Neuro position peaked at $2K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.